Table 1 Cost-effectiveness outcomes ($AU)

From: Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes

Stage

Cost of stage

QALY gain per stage

Cumulative cost

Cumulative QALY gain

Cumulative ICER

Cohort outcomes

$230,226.67

7.39

$230,226.67

7.39

$31,144.35

Cohort + cascade outcomes

$11,927.50

4.23

$242,154.17

11.62

$20,839.57

Cohort + cascade + reproductive outcomes

$270,351.42

24.38

$512,505.59

36.00

$14,235.28

  1. ICER incremental cost-effectiveness ratio, QALY quality adjusted life-year.
Back to article page